It is a colorless to light yellow liquid and is the mian raw material of atorvastatin calcium.
This report contains market size and forecasts of (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) in global, including the following market information:
Global (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) companies in 2021 (%)
The global (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity: 98%-99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) include Manus Aktteva Biopharma, Finetech, Pilarquim, Jiangsu WNC Pharmaceutical, Jiangxi Aifeimu Technology, Hangzhou Brother Bio-Technology, Suzhou Lead Biotechnology, Henan Yuchen Pharmaceutical and Zhejiang Hongyuan Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) Market Segment Percentages, by Type, 2021 (%)
Purity: 98%-99%
Purity Above 99%
Global (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) Market Segment Percentages, by Application, 2021 (%)
Atorvastatin Calcium
Other Medicines
Global (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) revenues share in global market, 2021 (%)
Key companies (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies (3R)-4-Cyano-3-Hydroxybutyric Acid Ethyl Ester (CAS 141942-85-0) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Manus Aktteva Biopharma
Finetech
Pilarquim
Jiangsu WNC Pharmaceutical
Jiangxi Aifeimu Technology
Hangzhou Brother Bio-Technology
Suzhou Lead Biotechnology
Henan Yuchen Pharmaceutical
Zhejiang Hongyuan Pharmaceutical